ATE323288T1 - Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregaten - Google Patents
Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregatenInfo
- Publication number
- ATE323288T1 ATE323288T1 AT98943817T AT98943817T ATE323288T1 AT E323288 T1 ATE323288 T1 AT E323288T1 AT 98943817 T AT98943817 T AT 98943817T AT 98943817 T AT98943817 T AT 98943817T AT E323288 T1 ATE323288 T1 AT E323288T1
- Authority
- AT
- Austria
- Prior art keywords
- disease
- fibriles
- protein aggregates
- amyloid
- aggregates
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000011835 investigation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97113320 | 1997-08-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE323288T1 true ATE323288T1 (de) | 2006-04-15 |
Family
ID=8227164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98943817T ATE323288T1 (de) | 1997-08-01 | 1998-07-31 | Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregaten |
Country Status (3)
| Country | Link |
|---|---|
| AT (1) | ATE323288T1 (de) |
| DE (1) | DE69834193T2 (de) |
| WO (1) | WO1999006838A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6846640B2 (en) | 2002-04-30 | 2005-01-25 | Pharmacia & Upjohn Company | Time-resolved fluorescence assay for the detection of multimeric forms of A-beta 1-40 |
| EA201790165A1 (ru) | 2014-07-29 | 2017-07-31 | Нейриммьюн Холдинг Аг | Происходящие от человека антитела к гентингтину (htt) и их применение |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8516081D0 (en) * | 1985-06-25 | 1985-07-31 | Ciba Geigy Ag | Assay & purification of amyloid components |
| US5234814A (en) * | 1989-06-01 | 1993-08-10 | Du Pont Merck Pharmaceutical Company | Diagnostic assay for alzheimer's disease |
| WO1996012544A1 (en) * | 1994-10-19 | 1996-05-02 | The General Hospital Corporation | A DIAGNOSTIC ASSAY FOR ALZHEIMER'S DISEASE: ASSESSMENT OF Aβ ABNORMALITIES |
| GB9701045D0 (en) * | 1997-01-18 | 1997-03-05 | Narang Harash K | Diagnosis of neuro-degenerative disorders |
-
1998
- 1998-07-31 WO PCT/EP1998/004810 patent/WO1999006838A2/en not_active Ceased
- 1998-07-31 DE DE69834193T patent/DE69834193T2/de not_active Expired - Lifetime
- 1998-07-31 AT AT98943817T patent/ATE323288T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69834193D1 (de) | 2006-05-24 |
| WO1999006838A3 (en) | 1999-07-08 |
| WO1999006838A2 (en) | 1999-02-11 |
| DE69834193T2 (de) | 2007-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE491721T1 (de) | Zusammensetzung und verfahren zum nachweis von krankheiten in zusammenhang mit der bildung von amyloid-ähnlichen fibrillen oder protein- aggregaten | |
| DE69227380D1 (de) | Verfahren zur bestimmung und behandlung von alzheimer-krankheit | |
| ATE300052T1 (de) | Verwendung von radioliganden zum screening von inhibitoren der herstellung von beta-amyloid peptiden | |
| ATE239797T1 (de) | Antikörper gegen beta-amyloid oder derivative davon und seine verwendung | |
| DE69837015D1 (de) | Verfahren zur Stabilisierung und Messung von Troponinkomplexen | |
| ATE420204T1 (de) | Verfahren zur detektion von erkrankungen | |
| ATE540319T1 (de) | Verfahren für die bestimmung von fk506 | |
| DE58908694D1 (de) | Oligonucleotidbank und verfahren zur dna-sequenzierung. | |
| ATE313802T1 (de) | Bestimmung von adrenomedullin-bindenden proteinen | |
| DE59912716D1 (de) | Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür | |
| ATE292801T1 (de) | Verfahren zum screening von inhibitoren von asp2 | |
| ATE545658T1 (de) | Verfahren zur behandlung von synovialsarkom | |
| ATE240743T1 (de) | Verfahren und substanzen gegen protozoen | |
| DE60035693D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
| DE69433243D1 (de) | Verwendunf von ApoE zum Binden von TAU und MAP2c Proteinen und zur Behandlung von Alzheimer's Krankheit | |
| EP1109929A4 (de) | Verfahren zur diagnose von magensalz-schwundsyndrom und alzheimerscher krankheit und behandlungsverfahren | |
| DE69108439D1 (de) | Verfahren zur Bestimmung des Glykationsprozentsatzes eines bestimmten Proteins. | |
| WO2002046767A3 (en) | Diagnosis and treatment of alzheimer's disease | |
| ATE323288T1 (de) | Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregaten | |
| DE69621837D1 (de) | Methoden zur feststellung von alzheimerscher krankheit | |
| DE60144493D1 (de) | Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen | |
| DE69525287D1 (de) | Endotoxin-Stabilisierungsmittel, Endotoxin-Zusammensetzung und Verfahren zur Bestimmung von Endotoxin | |
| EP0981357A4 (de) | Verfahren und zusammensetzungen zur diagnose und behandlung von neuropsychiatrischen erkrankungen | |
| ATE187738T1 (de) | Verfahren zur identifizierung und herstellung von bindungsstellen aufeinanderwirkender proteine | |
| DE69839733D1 (de) | Mit syndekan interagierende proteine und deren verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |